As for metabolism disorders, dysregulated glucose metabolism and insulin resistance stimulate insulin secretion, increasing hepatic triglyceride synthesis, which elevates plasma triglycerides and promotes NAFLD progression (89). This evidence concerns the gene INS and metabolic disease.